-
公开(公告)号:KR1020030013585A
公开(公告)日:2003-02-15
申请号:KR1020010047663
申请日:2001-08-08
Applicant: 충남대학교산학협력단
IPC: C12N15/86
CPC classification number: C12N7/02 , C12N5/067 , C12N15/86 , C12N2770/24223 , C12N2770/24251 , C12N2770/36141
Abstract: PURPOSE: Provided is a preparation of infectious HCV-like particles which are characteristically used as antigens for the detection HCV vaccine or HCV antibodies and for the inspection or examination of infection inhibiting drugs. CONSTITUTION: The preparation of infectious HCV-like particles is characterized by using a recombinant alphavirus expression vector(KCCM-10287) and a helper vector(KCCM-10286) which express HCV core, E1 and E2.
Abstract translation: 目的:提供特征性地用作检测HCV疫苗或HCV抗体的抗原以及感染抑制药物的检查或检查的感染性HCV样颗粒的制剂。 构成:感染性HCV样颗粒的制备的特征在于使用表达HCV核心,E1和E2的重组甲病毒表达载体(KCCM-10287)和辅助载体(KCCM-10286)。
-
公开(公告)号:KR100457790B1
公开(公告)日:2004-12-08
申请号:KR1020010047663
申请日:2001-08-08
Applicant: 충남대학교산학협력단
IPC: C12N15/86
Abstract: PURPOSE: Provided is a preparation of infectious HCV-like particles which are characteristically used as antigens for the detection HCV vaccine or HCV antibodies and for the inspection or examination of infection inhibiting drugs. CONSTITUTION: The preparation of infectious HCV-like particles is characterized by using a recombinant alphavirus expression vector(KCCM-10287) and a helper vector(KCCM-10286) which express HCV core, E1 and E2.
Abstract translation: 目的:提供一种感染性HCV样颗粒的制备物,其特征性地用作检测HCV疫苗或HCV抗体的抗原以及检测或检查感染抑制药物。 构成:通过使用表达HCV核心,E1和E2的重组α病毒表达载体(KCCM-10287)和辅助载体(KCCM-10286)来表征感染性HCV样颗粒的制备。
-